NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Masimo Corporation (NasdaqGS: MASI) to Danaher Corporation (NYSE: DHR). Under the terms of the proposed transaction, shareholders of Masimo will receive $180.00 in cash for each share of Masimo that they own. KSF is seeking to determine whether this consideration and the process that led to it are ad.

Fulton Breakefield Broenniman LLC lowered its position in Danaher Corporation (NYSE: DHR) by 27.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 48,301 shares of the conglomerate's stock after selling 18,647 shares during the quarter. Fulton Breakefield Broenniman LLC's holdings

Danaher is an American healthcare company that manufactures and markets products used for advances in biotechnology, life sciences, and diagnostics. Danaher has increased its dividend for 13 consecutive years. And its dividend growth has been nothing short of spectacular. DHR has a strong financial position. Its long-term debt/equity ratio is 0.3, while the interest coverage ratio is 17.

Runnymede Capital Advisors Inc. bought a new position in Danaher Corporation (NYSE: DHR) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 3,658 shares of the conglomerate's stock, valued at approximately $837,000. Several other institutional investors and hedge funds have also recently modified their holdings of

Ascent Group LLC increased its position in Danaher Corporation (NYSE: DHR) by 28.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 12,723 shares of the conglomerate's stock after acquiring an additional 2,811 shares during the period. Ascent Group LLC's

FNY Investment Advisers LLC grew its holdings in Danaher Corporation (NYSE: DHR) by 16,106.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,700 shares of the conglomerate's stock after acquiring an additional 4,671 shares during the period. FNY Investment

Defender Capital LLC. acquired a new stake in shares of Danaher Corporation (NYSE: DHR) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 156,015 shares of the conglomerate's stock, valued at approximately $35,715,000. Danaher makes up about 11.6% of Defender

First Bank and Trust bought a new position in shares of Danaher Corporation (NYSE: DHR) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 4,610 shares of the conglomerate's stock, valued at approximately $1,055,000. Other institutional investors and hedge funds also recently

Carderock Capital Management Inc. increased its position in shares of Danaher Corporation (NYSE: DHR) by 15.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 24,465 shares of the conglomerate's stock after buying an additional 3,362 shares during the period.

Danaher (NYSE: DHR - Get Free Report) and IceCure Medical (NASDAQ: ICCM - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, institutional ownership, dividends, valuation and risk. Institutional and Insider Ownership 79.1% of Danaher shares are